107 related articles for article (PubMed ID: 22155557)
1. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
2. Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis.
Miozzo SAS; John JA; Appel-da-Silva MC; Dossin IA; Tovo CV; Mattos AA
World J Hepatol; 2017 Dec; 9(35):1278-1285. PubMed ID: 29290909
[TBL] [Abstract][Full Text] [Related]
3. High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study.
Yoon JS; Hong JH; Park SY; Kim SU; Kim HY; Kim JY; Hur MH; Park MK; Lee YB; Lee HA; Kim GA; Sinn DH; Park SJ; Lee YJ; Kim YJ; Yoon JH; Lee JH
Aliment Pharmacol Ther; 2024 Apr; 59(8):973-983. PubMed ID: 38389319
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites.
Badal J; Badal B; Nawras M; Lee-Smith W; Stanley S; Hassan M; Ahmed Z
Dig Dis Sci; 2024 Apr; 69(4):1454-1466. PubMed ID: 38217676
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor Use and Complications of Cirrhosis Are Linked With Distinct Gut Microbial Bacteriophage and Eukaryotic Viral-Like Particle Signatures in Cirrhosis.
Peña Rodríguez M; Fagan A; Sikaroodi M; Gillevet PM; Bajaj JS
Clin Transl Gastroenterol; 2024 Feb; 15(2):e00659. PubMed ID: 37937851
[TBL] [Abstract][Full Text] [Related]
6. Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial.
China L; Tittanegro T; Crocombe D; Forrest E; Kallis Y; Ryder SD; Wright G; Freemantle N; O'Brien A
EClinicalMedicine; 2023 Apr; 58():101924. PubMed ID: 37090442
[TBL] [Abstract][Full Text] [Related]
7. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.
Deshpande A; Pasupuleti V; Thota P; Pant C; Mapara S; Hassan S; Rolston DD; Sferra TJ; Hernandez AV
J Gastroenterol Hepatol; 2013 Feb; 28(2):235-42. PubMed ID: 23190338
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
9. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Ratelle M; Perreault S; Villeneuve JP; Tremblay L
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
[TBL] [Abstract][Full Text] [Related]
11. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Dam G; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
[TBL] [Abstract][Full Text] [Related]
13. Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.
Kwon JH; Koh SJ; Kim W; Jung YJ; Kim JW; Kim BG; Lee KL; Im JP; Kim YJ; Kim JS; Yoon JH; Lee HS; Jung HC
J Gastroenterol Hepatol; 2014 Apr; 29(4):775-81. PubMed ID: 24219827
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.
Miura K; Tanaka A; Yamamoto T; Adachi M; Takikawa H
Intern Med; 2014; 53(10):1037-42. PubMed ID: 24827481
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and association with spontaneous bacterial peritonitis in patients with cirrhosis and ascites.
Siple JF; Morey JM; Gutman TE; Weinberg KL; Collins PD
Ann Pharmacother; 2012 Oct; 46(10):1413-8. PubMed ID: 23032651
[TBL] [Abstract][Full Text] [Related]
16. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
van Vlerken LG; Huisman EJ; van Hoek B; Renooij W; de Rooij FW; Siersema PD; van Erpecum KJ
Eur J Clin Invest; 2012 Jul; 42(7):760-7. PubMed ID: 22288900
[TBL] [Abstract][Full Text] [Related]
17. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
Xu HB; Wang HD; Li CH; Ye S; Dong MS; Xia QJ; Zhang AQ; Pan K; Ge XL; Dong JH
Genet Mol Res; 2015 Jul; 14(3):7490-501. PubMed ID: 26214428
[TBL] [Abstract][Full Text] [Related]
20. Sexually transmitted diseases treatment guidelines, 2015.
Workowski KA; Bolan GA;
MMWR Recomm Rep; 2015 Jun; 64(RR-03):1-137. PubMed ID: 26042815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]